Cargando…

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795296/ http://dx.doi.org/10.1007/s40278-022-09513-5

Ejemplares similares

Ruxolitinib for severe fever with thrombocytopenia syndrome (SFTS)
por: Wen, Sai, et al.
Publicado: (2022)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
por: Sarmiento Maldonado, Mauricio, et al.
Publicado: (2017)

Ruxolitinib: Viral respiratory infections: case report
Publicado: (2019)

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report
por: Furia, Francesca, et al.
Publicado: (2020)

Ruxolitinib: Grade 3 liver toxicity following off-label use: case report
Publicado: (2020)

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib
por: Abidi, Maheen Z., et al.
Publicado: (2016)

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib
por: Pálmason, Róbert, et al.
Publicado: (2015)

Ruxolitinib found to cause eyelash growth: a case report
por: Song, Julia, et al.
Publicado: (2017)

Topical ruxolitinib for the treatment of granuloma faciale
por: Wong, Alan, et al.
Publicado: (2023)

Ruxolitinib cream for the treatment of cutaneous sarcoidosis
por: Smith, Jeffrey S., et al.
Publicado: (2023)

Ruxolitinib for myelofibrosis
por: GU, LIAN, et al.
Publicado: (2013)

Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report
por: Broser, Philip, et al.
Publicado: (2022)

Methylprednisolone/prednisolone/ruxolitinib: Masked fever and lack of efficacy: case report
Publicado: (2022)

Ruxolitinib: Immunosuppression leading to impaired viral RNA clearance: case report
Publicado: (2021)

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
por: Vannucchi, Alessandro M., et al.
Publicado: (2020)

Treatment of cutaneous lupus with topical ruxolitinib cream
por: Park, Jonathan J., et al.
Publicado: (2022)

Delayed granulomatous eruption of the nose associated with ruxolitinib
por: Brown, Margaret, et al.
Publicado: (2020)

Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Cryptococcal infection with ruxolitinib in primary myelofibrosis: A case report and literature review
por: Ciochetto, Zachary, et al.
Publicado: (2022)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation
por: Mortara, Andrea, et al.
Publicado: (2021)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Ruxolitinib-Associated Phaeohyphomycosis: A Case Report
por: Marples, Rory, et al.
Publicado: (2021)

Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
por: Sandhu, Sunny, et al.
Publicado: (2022)

Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis
por: Pope, Eleanor, et al.
Publicado: (2022)

Development of sebaceous carcinoma in a patient on ruxolitinib therapy
por: Mohsin, Noreen, et al.
Publicado: (2022)

Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump
por: Shamil, Eamon, et al.
Publicado: (2015)

Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib
por: Sakiyama, Emiko, et al.
Publicado: (2020)

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
por: Jaramillo, Sonia, et al.
Publicado: (2020)

Ruxolitinib: Rebound effect manifested as acute hypoxaemic respiratory failure: 3 case reports
Publicado: (2021)

P1044: REAL-WORLD RUXOLITINIB TREATMENT PATTERN IN MYELOFIBROSIS PATIENTS WITH THROMBOCYTOPENIA
por: Mei, J., et al.
Publicado: (2022)

Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report
por: Wang, Lina, et al.
Publicado: (2023)

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
por: Hirano, Anna, et al.
Publicado: (2017)

Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient
por: Peterson, Danielle M., et al.
Publicado: (2020)

A case report of cryptococcal meningitis associated with ruxolitinib
por: Tsukui, Daisuke, et al.
Publicado: (2020)

Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016)

Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor
por: Manduzio, Palma
Publicado: (2017)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ho5g74r17q10rgrg9bot5okn3u